T tumors including inflammatory breast cancer
No inflammatory breast cancer
T tumors including inflammatory breast cancer
T tumors including inflammatory breast cancer
Participant with inflammatory breast cancer.
Inflammatory breast cancer
Diagnosis of inflammatory breast cancer
FOR ALL PHASES (Ib AND II): Inflammatory breast cancer
Inflammatory breast cancer
Diagnosis of inflammatory breast carcinoma
Inflammatory (Td) breast cancer
Documentation of inflammatory breast cancer
Inflammatory breast cancer or patients with rapidly progressing metastatic breast cancer
Diagnosis of inflammatory breast cancer
Have no inflammatory breast cancers
Patients with bilateral or inflammatory breast cancer
Inflammatory breast cancer
Inflammatory breast cancer
Current diagnosis of invasive or inflammatory breast carcinoma
Patients with inflammatory breast carcinoma
Patients with inflammatory breast cancer
Bilateral or inflammatory breast cancer
Inflammatory breast cancer
Inflammatory breast cancer or tumor with deep adherence or cutaneous invasion
Diagnosis of inflammatory breast cancer
Patients must have the clinical diagnosis of inflammatory breast cancer
Patients with inflammatory breast cancer
Subject has inflammatory breast cancer
Inflammatory breast cancer
Patients must not have inflammatory breast cancer and must not have metastatic disease
Active inflammatory breast cancer
Patient with inflammatory breast cancer at screening
Subject has inflammatory breast cancer
Inflammatory breast cancer or tumor with deep adherence or cutaneous invasion;
Subjects with Inflammatory breast cancer.
Inflammatory breast cancer
Patient with inflammatory breast cancer at screening .
Patients who currently have inflammatory breast cancer at screening.
Have inflammatory breast cancer
Inflammatory/inoperable breast cancer.
Male and female participants with locally advanced, inflammatory, or early-stage, unilateral, and histologically confirmed invasive breast cancer. Participants with inflammatory breast cancer must be able to have a core needle biopsy
Evidence of inflammatory breast cancer
Inflammatory breast cancer.
Inflammatory breast cancer
Subjects with prior skin changes consistent with inflammatory breast carcinoma are eligible.
Patient with inflammatory breast cancer
Inflammatory or metaplastic breast cancer
Subjects with inflammatory breast cancer
Subjects with a diagnosis of non-inflammatory breast cancer or carcinoma in situ
Women with inflammatory breast cancer as evidenced by clinical assessment
Subjects with Inflammatory breast cancer.
Inflammatory breast malignancy
T tumors including inflammatory breast cancer
Participants with inflammatory breast cancer or multi-centric disease
Participants with locally advanced breast cancer such as inflammatory breast cancer or cancer grossly involving skin
Inflammatory breast cancer
Patients with stage T or greater (T-T), nodal involvement (N-N), without metastasis (M) invasive breast cancer, including patients with inflammatory breast cancer
Patients with invasive, inflammatory breast cancer or distant metastases will be excluded from participating in this study
Any patient with confirmed metastatic disease. Patients with inflammatory breast cancer.
Women with T disease, including inflammatory breast cancer
